Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea

Sleep

Volumn 22, Issue 1, 1999, Pages 61-67

  Kraiczi, Holger ^a   Hedner, Jan ^a   Dahlöf, Pia ^a   Ejnell, Hasse ^a   Carlson, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Obstructive sleep apnea; Polysomnography; Serotonin uptake inhibitors; Well being

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BREATHING PATTERN; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SLEEP APNEA SYNDROME;

ADULT; AGED; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PAROXETINE; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RESPIRATION; SEROTONIN UPTAKE INHIBITORS; SLEEP APNEA SYNDROMES; SLEEP, REM;

EID: 0033083954     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Tangel DJ, Mezzanotte WS, Sandberg EJ, White DP. Influences of NREM sleep on the activity of tonic vs. inspiratory phasic muscles in normal men. J Appl Physiol 1992;73(3):1058-1066.
2. Wheatley JR, Mezzanotte WS, Tangel DJ, White DP. Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 1993;148(3):597-605.
3. Horner RL, Innes JA, Morrell MJ, Shea SA, Guz A. The effect of sleep on reflex genioglossus muscle activation by stimuli of negative airway pressure in humans. J Physiol London 1994;476(1):141-151.
4. Remmers JE, DeGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978;44(6):931-938.
5. Deegan PC, McNicholas WT. Pathophysiology of obstructive sleep apnea. Eur Respir J 1995;8:1161-1178.
6. Kubin L, Reignier C, Tojima H, Taguchi O, Pack AI, Davies RO. Changes in serotonin level in the hypoglossal nucleus region during carbachol-induced atonia. Brain Res1994;645:291-302.
7. Kubin L, Tojima H, Davies RO, Pack AI. Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate cat. Neurosci Lett 1992;139:243-248.
8. Rose D, Khater-Boidin J, Toussaint P, Duron B. Central effects of 5-HT on respiratory and hypoglossal activities in the adult cat. Resp Physiol 1995;101:59-69.
9. Veasey S, Panckeri KA, Hoffman EA, Pack AI, Hendricks JC. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 1996;153:776-86.
10. Schmidt HS. L-tryptophan in the treatment of impaired respiration in sleep. Bull Europ Physiopath Resp 1983;19:625-629.
11. Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 1991;100:416-421.
12. Fuller RW. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 1994;55(3):163-167.
13. Visser T, Oostelbos MC, Toll PJ. Reliable routine method for the determination of antidepressant drugs in plasma by high-performance liquid chromatography. J Chromatogr 1984;309(1):81-93.
14. Rechtschaffen A, Kales AA. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Department of Health, Education and Welfare, Public Health Service, Bethesda, 1968.
15. Åsberg M, Perris C, Schalling D, Sedvall G. The CPRS - development and applications of a psychiatric rating scale. Acta Psychiat Scand 1978;271 Supplement:5-27.
16. Montgomery S, Åsberg M, Jörnestedt L, Thorén P, Träskman L, McAuley R, Montgomery D, Shaw P. Reliability of the CPRS between the disciplines of psychiatry, general practice, nursing and psychology in depressed patient. Acta Psychiat Scand 1978;271 Supplement:29-32.
17. Dahlöf P, Ejnell H, Hällström T, Hedner J. Surgical treatment of the sleep apnea syndrome reduces concomitant major depression. Acta Psychiat Scand 1998 (In Press).
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, Revised. Washington DC: American Psychiatric Association, 1982.
19. Jones B, Kenward MG. Design and Analysis of Cross-Over Trials. London, New York, Tokyo, Melbourne, Madras: Chapman and Hall, 1989:30-39.
20. Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J Clin Psychiat 1992;53(2 Supplement):7-12.
21. Thomas DR, Nelson DR, Johnson AM. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology-Berl 1987;93:193-200.
22. Briley M, Moret C. Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 1993;16(5):387-400.
23. Chaput Y, de-Montigny C, Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacol 1991;5(4):219-229.
24. Blier P, Chaput Y, de-Montigny C. Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. N-S Arch Pharmacol 1991;337(3):246-254.
25. Rutter JJ, Gudlah C, Auerbach SB. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 1994;171(1-2):183-186.
26. Hudgel DW, Gordon EA, Meltzer HY. Abnormal serotonergic stimulation of cortisol production in obstructive sleep apnea. Am J Respir Crit Care Med 1995;152:186-192.
27. Baumann P. Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharm 1996;11 Supplement 1:5-11.
28. Lundmark J, Walinder J, Alling C, Manniche PM, Dalgaard L. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. Eur Neuropsychopharmacol 1994;4(1):1-6.
29. Fuller RW. Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. Prog Drug Res 1995;45:167-204.
30. McGinty D, Harper RM. Dorsal raphe neurons: depression of firing during sleep. Brain Res 1976;101:567-575.
31. Trulson ME, Jacobs BJ. Raphe unit activity in freely moving cats: correlation with the level of behavioural arousal. Brain Res 1979;163: 135-150.
32. Iwakiri H, Matsuyama K, Mori S. Extracellular levels of serotonin in the medial pontine reticular formation in relation to sleep wake cycle in cats: a microdialysis study. Neurosci Res 1993;18(2):157-170.
33. Portas CM, McCarley RW. Behavioral state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus: a microdialysis study in the freely moving cat. Brain Res 1994;648(2):306-312.
34. Vasar V, Appelberg B, Rimón R, Selvaratnam J. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers. Int Clin Psychopharm 1994;9:203-206.
35. Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo-controlled trial. Psychopharmacology-Berl 1996;126(1):50-54.
36. Borbély AA, Åkerstedt T, Benoit O, Holsboer F, Oswald I. Hypnotics and sleep physiology: a consensus report. Eur Arch Psychiatry Clin Neurosci 1991;241:13-21.
37. Svanborg E, Guilleminault C. EEG frequency changes during sleep apneas. Sleep 1996;19(3):248-254.
38. Caley CF, Weber SS. Paroxetine: a selective serotonin reuptake inhibiting antidepressant. Ann Pharmacother 1993;27:1212-1222.